A new option for EPI
AzurRx completes enrollment in Phase 2 clinical trial of MS1819 in combination with PERT to treat cystic fibrosis patients with severe exocrine pancreatic insufficiency
gastroenterology
Ingestible capsule offers in-depth diagnostics
Progenity presents results on PIL Dx capsule in small intestinal bacterial overgrowth
